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Rac1 small GTPase controls essential aspects of cell
biology and is a direct target of numerous bacterial
virulence factors. The CNF1 toxin of pathogenic
Escherichia coli addresses Rac1 to ubiquitin-protea-
some system (UPS). We report the essential role of
the tumor suppressor HACE1, a HECT-domain con-
taining E3 ubiquitin-ligase, in the targeting of Rac1
to UPS. HACE1 binds preferentially GTP-bound
Rac1 and catalyzes its polyubiquitylation. HACE1
expression increases the ubiquitylation of Rac1,
when the GTPase is activated by point mutations or
by the GEF-domain of Dbl. RNAi-mediated depletion
of HACE1 blocks the ubiquitylation of active Rac1
and increases GTP-bound Rac1 cellular levels.
HACE1 antagonizes cell isotropic spreading, a hall-
mark of Rac1 activation, and is required for endothe-
lial cell monolayer invasion by bacteria. Together,
these data establish the role of the HACE1 E3 ubiqui-
tin-ligase in controlling Rac1 ubiquitylation and
activity.
INTRODUCTION
Rac1 belongs to the Rho family of small GTPases (Jaffe and Hall,
2005; Heasman and Ridley, 2008). This signaling protein inte-
grates cues emanating from cell surface receptors to control
cytoskeleton-dependent processes (Heasman and Ridley,
2008). In addition, Rac1 is a direct target of pathogenic bacteria
virulence factors (Aktories, 2011; Boquet and Lemichez, 2003).
Rac1 undergoes a temporal regulation primarily controlled by
two families of factors (Heasman and Ridley, 2008). Guanine
nucleotide exchange factors (GEFs) catalyze the exchange of
guanosine diphosphate (GDP) for guanosine triphosphate
(GTP). GTPase activating proteins (GAPs) catalyze GTP hydro-
lysis. Upon GTP loading, Rac1 undergoes a conformationalDevelopmechange of its switch-I region allowing it to bind and activate
effector proteins (Jaffe and Hall, 2005; Vetter and Wittinghofer,
2001). This GTPase-activity based temporal regulation of Rac1
allows a tight control of cellular levels of GTP-boundRac1, deter-
mining the amplitude of its signaling and downstream cellular
effects (Heasman and Ridley, 2008).
Recent advances point to a contributing role of the ubiquitin-
mediated proteasomal degradation of GTP-bound Rac1 in the
control of its signaling (Nethe and Hordijk, 2010; Visvikis et al.,
2010). Studies on the cytotoxic necrotizing factor-1 (CNF1),
and other related bacterial toxins, have been instrumental in
unraveling and deciphering the importance of the regulation of
Rac1 by ubiquitin-mediated proteasomal degradation (Aktories,
2011; Doye et al., 2002; Visvikis et al., 2010). CNF1 toxin is
produced by uropathogenic Escherichia coli (UPEC), the primary
causative agents of urinary tract infections (UTIs) frequently
responsible of bacteremia (Lemonnier et al., 2007; Xie et al.,
2004). This toxin enters host cells by receptor-mediated endocy-
tosis and targets Rho proteins by posttranslational modification
(Lemonnier et al., 2007). Indeed, CNF1 catalyzes the deamida-
tion of a conserved glutamine residue of Rho GTPases (Q61
for Rac1) into glutamic acid (Flatau et al., 1997; Lerm et al.,
1999; Schmidt et al., 1997). This produces a reduction of Rac1
intrinsic and GAP-stimulated GTPase activity, leading to its
permanent activation (Lerm et al., 1999). Nevertheless, activa-
tion of Rac1 sensitizes this GTPase to ubiquitin-mediated pro-
teasomal degradation (Doye et al., 2002; Lynch et al., 2006;
Nethe and Hordijk, 2010; Visvikis et al., 2010). Posttranslational
modification of proteins by ubiquitylation involves the covalent
attachment of ubiquitin, an 8-kDa polypeptide, to lysine residues
on the target, through a cascade of transfer reactions between
ubiquitin-carrier proteins (Weissman, 2001). Binding of target
proteins by E3 ubiquitin-ligases confers substrate specificity to
the reaction (Marı´n, 2010; Weissman, 2001). Additional mole-
cules of ubiquitin can subsequently be attached to one of the
seven lysines of the previously crosslinked ubiquitin molecule,
leading to the formation of various types of polyubiquitin chains.
Assembly of lysine-48 (K48) polyubiquitin chains on proteins is
a canonical signal of targeting to the 26S proteasome degrada-
tive machinery (Weissman, 2001). Once activated, for instancental Cell 21, 959–965, November 15, 2011 ª2011 Elsevier Inc. 959
Figure 1. HACE1 Controls CNF1-Induced
Degradation of Rac1
(A) Percentage of siRNA-mediated protection
against CNF1-induced Rac1 degradation. Cells
were transfected with siRNA control (siCtrl) or
targeting each of the 27-known HECT-domain
containing E3 ubiquitin-ligases and next in-
toxicated 24 hr with CNF1 108 M. Rac1 levels
were assessed by anti-Rac1 Enzyme-linked
immunosorbent assay (ELISA). Values corre-
sponding to Rac1 levels in siCtrl+CNF1 and siCtrl
nonintoxicated cells were set to 0 and 100%,
respectively. Data showmean of triplicates ± SEM
(*p = 0.05; **p < 0.01).
(B) Immunoblots (IB) show the inhibitory effect of
HACE1 depletion on CNF1-induced Rac1 degra-
dation. Cells were transfected with control siRNA
(siCtrl) or HACE1 targeting siRNAs (siRNA mix:
siHm or single sequence from the mix: siHs).
Cells were left untreated or treated 8 hr with CNF1
109 M. Immunoblots anti-Rac1 and anti-RhoA
showcellular levelsof theseGTPases. Immunoblots
anti-RhoGDI or anti-b-actin show equal loading.
(C) Percentage of cellular depletion of Rac1 and
RhoA in cells transfected with different siRNAs
and intoxicated 8 hr with CNF1 109 M, as com-
pared to nonintoxicated conditions. Data show
mean ± SEM, n = 3 independent experiments
(**p < 0.01, ***p < 0.001, ns: not significant).
Developmental Cell
Ubiquitylation of Rac1 by HACE1 E3-Ligaseby CNF1 or hepatocyte growth factor (HGF), Rac1 undergoes
a K48-polyubiquitylation and proteasomal degradation (Doye
et al., 2002; Lynch et al., 2006). Efficiency of Rac1 ubiquitylation
depends of the extent of Rac1 activation, being maximal upon
mutation of the glutamine 61 into leucine (Doye et al., 2002). In
CNF1 intoxicated cells, the faster kinetics of Rac1 ubiquitylation
and proteasomal degradation, over that of Rac1 synthesis, leads
to a progressive depletion of Rac1 (Doye et al., 2002, 2006;
Munro et al., 2004). The ubiquitin-proteasome system (UPS)-
mediated degradation of Rac1 is required for the HGF-mediated
epithelial cell scattering and invasion of uroepithelial cells by
UPEC producing CNF1 (Doye et al., 2002; Lynch et al., 2006).
Considering that dysfunction of Rac1 signaling is implicated in




of Rac1 Requires HACE1
We previously demonstrated that activation of Rac1 by CNF1
leads to a targeting of this GTPase to the UPS for degradation
(Doye et al., 2002). In order to identify the E3 ubiquitin-ligase
controlling Rac1 degradation, we established a screening
method, based on CNF1 property. The small GTPase RhoA is
ubiquitylated by Smurf1, a HECT (homologous to E6-associated960 Developmental Cell 21, 959–965, November 15, 2011 ª2011 Elsevier Inc.protein C terminus)-domain containing
E3 ubiquitin ligase (Boyer et al., 2006;
Ozdamar et al., 2005; Wang et al.,
2003). Thus, we hypothesized a possible
conservation of regulation and assessedthe involvement of this type of E3-ligase in Rac1 degradation.
We transfected cells with a siRNA library targeting the 27-known
human HECT-domain containing E3 ubiquitin-ligases (Marı´n,
2010). Next, cells were intoxicated with CNF1 to induce the ubiq-
uitin-mediated proteasomal degradation of Rac1. SiRNA-medi-
ated protective effect on Rac1 degradation was monitored by
ELISA. HACE1 depletion had the most significant inhibitory
effect on Rac1 degradation, as compared to control siRNA
(siCtrl) conditions (Figure 1A). The HECT domain and ankyrin
repeat containing E3 ubiquitin protein ligase 1 (HACE1) is amajor
tumor suppressor of unknown target (Zhang et al., 2007). We
further monitored the blockade of Rac1 degradation in HACE1
knocked down cells by immunoblotting. We determined optimal
conditions that reduced HACE1 mRNA by at least 80%, using
amix of three siRNA (siHm), and defined a single siRNA sequence
(siHs) leading to 70% HACE1 mRNA depletion (see Figure S1A
available online). Under these conditions, we established that
HACE1 is required for UPS-mediated degradation of Rac1, as
the degradation of Rac1 induced by CNF1 was impaired in
HACE1 depleted cells (Figures 1B and 1C). We confirmed that
HACE1 regulates Rac1 at the protein level because it had no
impact on Rac1 mRNA levels (Figure S1A). CNF1 also triggers
the UPS-mediated degradation of RhoA (Doye et al., 2002). We
measured that HACE1 knockdown had no impact on the degra-
dation of RhoA, thereby indicating a specific targeting of Rac1
by HACE1 (Figures 1B and 1C). We also verified that the
Figure 2. HACE1 Ubiquitylates Active Rac1 In Vitro
(A and B) In vitro ubiquitylation of Rac1 byHACE1 revealed
by anti-ubiquitin immunoblot (IB: Ub). Rac1 immunoblot
controls are shown in Figures S2A and S2B. The profile
shows ubiquitylated forms of Rac1 (Rac1-Ubn). (A) Ubiq-
uitylation assay performed with recombinant Rac1,
HACE1 wild-type, or catalytically inactive mutant C876S
(HACE1-CS), together with indicated components. (B)
GTP-dependent ubiquitylation of Rac1 by HACE1. Re-
combinant Rac1 loaded with GTP, GDP, or the Mg2+-free
form (EDTA) were used in the ubiquitylation reaction.
(C) Direct association of HACE1 and Rac1 in vitro (Pull-
down). Beads coupled to glutathione S-transferase (GST)
or GST-HACE1 were incubated with recombinant purified
Rac1 (Rac1), the Mg2+-free form of Rac1 (EDTA), or Rac1
loaded with GDP or GTPgS, as indicated. HACE1-asso-
ciated Rac1 (top: Rac1) and input Rac1 (bottom) were
determined by Rac1 immunoblotting (IB: Rac1). GST
proteins were detected by amido black staining (GST or
GST-HACE1).
(D) Immunoblotting anti-Rac1 showing, as a control, the
specific binding of GTPgS-loaded Rac1 to GST-PAK,
(Pull-down). GST-PAK70-106 was incubated with recom-
binant purified Rac1 (Rac1), the Mg2+-free form of Rac1
(EDTA), or Rac1 loaded with GDP or GTPgS, as indicated.
Association of Rac1 with GST-PAK70-106 was revealed by
Rac1 immunoblotting (IB: Rac1). GST-PAK70-106 protein
was detected by amido black staining (GST-PAK).
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Ubiquitylation of Rac1 by HACE1 E3-LigasesiRNA-targeted depletion of two other E3 ubiquitin-ligases
KIAA0317 and TRIP12 had no effect on Rac1 degradation, indi-
cating low likelihood of off-target effects (Figures S1A and S1B).
Blocking protein synthesis did not interfere with the protective
effect of HACE1 knockdown on CNF1-induced Rac1 degrada-
tion (Figure S1C). Thus HACE1 knockdown acts by preventing
Rac1 UPS-mediated degradation, rather than by increasing
Rac1 synthesis. Collectively, these data establish that HACE1
controls the UPS-mediated degradation of Rac1 in cells intoxi-
cated by CNF1.
HACE1 Catalyzes the Ubiquitylation of GTP-Bound Rac1
In Vitro
HACE1 is a HECT-domain containing E3 enzyme of unknown
target. To determine whether Rac1 is a substrate of the HACE1
ubiquitin ligase, we set up an in vitro ubiquitylation assay. A
previous study established that HACE1, in combination with
the UbcH7 E2 enzyme, catalyzes its auto-ubiquitylation (Angle-
sio et al., 2004). We measured Rac1 ubiquitylation upon incuba-
tion of recombinant Rac1 with HACE1, the E2 enzyme UbcH7, in
addition to standard components required for in vitro ubiquityla-
tion assay (Anglesio et al., 2004). We found that UbcH7, as well
as E1 and ATP were all required for Rac1 ubiquitylation by
HACE1, thereby establishing the ability of HACE1 to catalyze
Rac1 ubiquitylation (Figure 2A and Figure S2A). HACE1 auto-
ubiquitylation requires a conserved cysteine residue in HECT-
domains (C876 of HACE1) involved in the transfer of ubiquitin
from the E2 enzyme to the target (Anglesio et al., 2004). Accord-
ingly, we found that mutation of HACE1 cysteine-876 into serine
(HACE1-CS) abolished its capacity to ubiquitylate Rac1 (Fig-
ure 2A). Importantly, we observed that ubiquitylation of Rac1
by HACE1 depends on Rac1 activation state. Loading of Rac1
with GTP was required for its ubiquitylation by HACE1, whereasDevelopmeinactive GDP-bound orMg2+-free forms of Rac1were both resis-
tant to ubiquitylation (Figure 2B and Figure S2B). We also
measured a direct binding of HACE1 to Rac1 in vitro, with a
2-fold (SEM = ± 0.5-fold) preferential binding to GTP-bound
Rac1, as compared to its GDP-bound form (Figures 2C and
2D). Altogether, these data establish that GTP-bound Rac1 is a
substrate of the E3 ubiquitin-ligase HACE1.
HACE1 Binds to Rac1 and Regulates Its Ubiquitylation
in Cells
We performed coimmunoprecipitation experiments to evaluate
the ability of HACE1 to associate with Rac1 in cells. Cells were
transfected with HA-tagged HACE1-CS together with Flag-
tagged dominant active (L61 and V12) or inactive (N17) mutant
forms of Rac1. HACE1 displayed higher affinity toward active
forms of Rac1 (Figure 3A). Moreover, we measured a higher
binding of HACE1 to Rac1 upon activation by CNF1 or expres-
sion of the GEF-domain of Dbl (Figures S3A and S3B). In parallel,
we observed a colocalization of HACE1 with Rac1L61 at the cell
periphery, in contrast to Rac1N17 (Figure 3B). Collectively this
defines the capacity of HACE1 to associate preferentially with
active Rac1. We next determined the importance of HACE1 in
controlling the ubiquitylation of active Rac1. We conducted
His-tagged ubiquitin precipitation experiments in various condi-
tions and visualized Rac1 ubiquitylation profile. Cell lysates were
normalized to total Rac1 cellular levels and His-tagged ubiquitin
crosslinked proteins were purified, as described in (Doye et al.,
2006). In HACE1 depleted cells, we observed a severe reduction
of the ubiquitylation of Rac1L61 and Rac1E61, the mutation
that mimics the modification catalyzed by CNF1 (Figure 3C
and Figure S3C). We reasoned that if HACE1 is a rate-limiting
factor, its overexpression should increase the ubiquitylation
of Rac1. Indeed, we found that overexpression of HACE1ntal Cell 21, 959–965, November 15, 2011 ª2011 Elsevier Inc. 961
Figure 3. HACE1 Activity Is Essential for
Rac1 Ubiquitylation in Cells
(A) Immunoprecipitation (IP) anti-Flag from cells
cotransfected with expression plasmids for Flag-
Rac1L61, Flag-Rac1V12, or Flag-Rac1N17 and
HA-HACE1-CS. Immunoblot anti-HA (IB: HA)
shows the preferential association of HACE1 with
Rac1L61 and Rac1V12 over Rac1N17. Immuno-
blot anti-Flag shows levels of immunoprecipitated
Rac1 mutants. Immunoblots on total lysates show
expression of constructs.
(B) Immunolocalization of HA-HACE1-CS (HACE1-
CS) and either GFP-Rac1L61 (Rac1L61) or YFP-
Rac1N17 (Rac1N17). Arrowheads indicate coloc-
alization of HACE1-CS with Rac1L61 at the edge
of cell (scale bar represents 10 mm).
(C–F) Immunoblots show Rac1 ubiquitylation in
cells in different experimental conditions. Cells
were transfected, as indicated, with expression
vectors of Histidine-tagged ubiquitin (His-Ub)
wild-type (WT), or K48R mutant (R48) together
with HA-Rac1, Flag-Rac1 mutants and myc-tag-
ged Dbl495-826 (referred to as myc-Dbl), or control
siRNA (Ctrl), HACE1 siRNA mix (Hm), and single
sequence (Hs). His-Ub crosslinked forms of Rac1
were purified (HisP), resolved on 12% (C, E, F) or
10% (D) SDS-PAGE and detected by immunoblot
to HA- or Flag-tags (Rac1-Ubn). Immunoblot anti-
HA or anti-Flag (lower panel) were performed in
parallel to verify the amounts of HA-Rac1 or Flag-
Rac1 proteins engaged in the His-Ub purifications.
(D, E, F) Immunoblots anti-HA show expression of
HA-HACE1 (WT) or (CS). (E) Immunoblot anti-myc
shows expression of myc-Dbl.
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Ubiquitylation of Rac1 by HACE1 E3-Ligaseincreased Rac1L61 ubiquitylation, whereas overexpressing cat-
alytically inactive HACE1 had an inhibitory effect on Rac1L61
ubiquitylation (Figure 3D). Similar results were obtained when
wild-type Rac1 was activated by expression of the GEF-domain
of Dbl (Figure 3E). This generalizes the capacity of HACE1 to
control the ubiquitylation of wild-type Rac1 upon its activation.
In addition, expression of K48R-ubiquitin mutant partially
shifted-down the polyubiquitylation profile of Rac1 in control
and HACE1 expressing cells, suggesting a contribution of K48-
ubiquitin crosslinking in polyubiquitin chains formation on Rac1
by HACE1 (Figure 3F). Collectively, these data establish that
HACE1 targets active Rac1 to control its ubiquitylation in cells.962 Developmental Cell 21, 959–965, November 15, 2011 ª2011 Elsevier Inc.HACE1 Controls Rac1 Activity
We reasoned that HACE1, by controlling
the UPS-mediated degradation of GTP-
bound Rac1, may modulate Rac1 activity
and downstream signaling. We assessed
variations of the level of GTP-bound Rac1
in HACE1 depleted cells. CNF1 induces
a transient activation of Rac1 due to
the targeting of activated-Rac1 to UPS
(Doye et al., 2002). Upon HACE1 knock-
down, we measured a sustained activa-
tion of Rac1 in CNF1 treated cells (Figures
4A and 4B). Furthermore, in nonintoxi-
cated cells, we measured an increase ofthe steady-state level of GTP-bound Rac1 after 48 hr of siHACE1
treatment (Figure 4B). Elevated activity of Rac1 promotes actin
cytoskeleton polymerization, as well as a formation of focal
complexes at the cell margin, leading to cell isotropic spreading
(Doye et al., 2002; Zaidel-Bar et al., 2003). In order to analyze
the function of HACE1 on Rac1 signaling, we monitored actin
cytoskeleton and adhesive structures by phalloidin and paxillin
staining, respectively (Figure 4C). In HACE1-depleted cells in-
toxicated by CNF1, we determined that a majority of cells dis-
played a circular and spread morphology associated with the
formation of focal complexes at their periphery (Figure 4C and
Figure S4A). Moreover, quantitativemeasurements of cell outline
Figure 4. HACE1 Regulates Rac1 Activity
(A) Rac1 activation at 0, 3, 6, and 10 hr of cell intoxication
by CNF1 109 M in cells transfected with control siRNA
(siCtrl) or HACE1 targeting siRNAmix (siHm). Immunoblots
show levels of GST-PAK associated GTP-bound Rac1
(Rac1-GTP) and total Rac1 in lysates (Rac1). Immunoblots
anti-b-actin show equal loading.
(B) Quantification of Rac1-GTP normalized to actin in
siCtrl, siHACE1 mix (siHm) or single (siHs) transfected cells
left untreated or intoxicated by CNF1 109 M, 15 hr. Data
show mean ± SEM, n = 3 independent experiments.
(C) Confocal sections showing actin cytoskeleton and
paxillin in cells transfected with siRNAs control, siHACE1
(siHs) and/or siRac1 and intoxicated 18 hr with 109 M
CNF1 (scale bar represents 10 mm).
(D) Quantification of circularity index of cell outline. A
circularity value of 1 corresponds to a perfect circle
(dotted line). Cells were transfected with siCtrl, siHs,
and/or siRac1 and intoxicated by 109 M CNF1 for 18 hr.
Data show mean ± SEM, nR 72 cells per condition, three
independent experiments.
(E) Efficiency of UPEC internalization into endothelial cells.
HUVEC monolayers were transfected with siCtrl, siHm, or
siRac1 and were then left untreated or were intoxicated
with 109 M CNF1, 18 hr prior to infection with bacteria.
Results are expressed as arbitrary units (A.U.). Data show
mean ± SEM, n = 3. Equal value of bacterial adhesion to
cells was verified in parallel (not shown).
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Ubiquitylation of Rac1 by HACE1 E3-Ligasedefined the increase of cell circularity in these conditions (Fig-
ure 4D). This change of cell morphology is consistent with the
high levels of GTP-bound Rac1 measured upon HACE1 deple-
tion (Figure 4B). This effect of HACE1 knockdown was reverted
upon RNAi-mediated depletion of Rac1 (Figures 4C and 4D).
Our functional analysis demonstrate that HACE1-mediated
UPS degradation of GTP-bound Rac1 is required to down-
modulate Rac1 activity and antagonize Rac1-dependent cell
isotropic spreading. CNF1 activity on Rac1 is essential for cell
invasion by pathogenic bacteria (Falzano et al., 1993; Visvikis
et al., 2011). Both the activation of Rac1 and its targeting to
UPS are required for efficient invasion of cells by UPEC (Doye
et al., 2002). Accordingly, we found that HACE1 depletion
dramatically reduced endothelial cell monolayer invasion by
pathogenic bacteria (Figure 4E). Together our data identify the
importance of HACE1 in the control of Rac1 ubiquitylation and
activity.Developmental Cell 21, 959–DISCUSSION
The study of CNF1 toxin had revealed that Rac1,
once activated, is prone to ubiquitin-mediated
proteasomal degradation by a yet uncharacter-
ized cellular ubiquitin-ligase (Visvikis et al.,
2010). Here, we established the posttransla-
tional modification of Rac1 byHACE1 E3 ubiqui-
tin-ligase as a key mode of regulation of this
GTPase and identify Rac1 as a target of the
tumor suppressor HACE1.
The ubiquitylation of proteins is subjected
to tight regulations to ensure the temporal de-
struction of the substrate. Previous findingshad established that Rac1 is targeted to UPS as a function of
the strength of its activation (Doye et al., 2002). Complementary
to these findings we show that HACE1 ubiquitin-ligase activity
has a strong specificity toward the GTP-bound form of Rac1.
In contrast, HACE1 binds GTP-bound Rac1 with a moderate
specificity. This suggests that GTP-bound Rac1 may activate
HACE1 upon interaction, for instance by unmasking its HECT-
domain. In cells, HACE1 catalyzes the ubiquitylation of Dbl-acti-
vated or mutant-active forms of Rac1. These data thus provide
molecular evidence that the ubiquitylation of Rac1 by HACE1
is controlled by guanine nucleotide-bound state of Rac1. Impor-
tantly, we here define that this regulation controls the cellular
level of active GTP-bound Rac1. In addition, we measured an
increase of the level of total Rac1 in HACE1 knocked down cells
suggesting that HACE1 controls both the activity and turnover of
Rac1 (Figure S4B). This increase of the level of total Rac1 re-
sulted in a low but reproducible raise of the GTP/total Rac1 ratio965, November 15, 2011 ª2011 Elsevier Inc. 963
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Ubiquitylation of Rac1 by HACE1 E3-Ligase(Figure S4C). Such a moderate increase of GTP/total Rac1 ratio
is likely due to the rapid rebalancing of GTP/GDP-bound forms
by cellular GEF/GAP factors rather than a targeting of both
guanine nucleotide-bound forms of Rac1 to UPS by HACE1.
These conclusions are supported by our in vitro data showing
the strong specificity of HACE1 ubiquitin-ligase activity toward
GTP-bound Rac1. Furthermore, the abrogation of Rac1 GTPase
activity by CNF1 resulted in a marked increase of the GTP/total
Rac1 ratio in HACE1 knocked down cells (Figure S4C). Collec-
tively, our data show that UPS-regulation of GTP-bound Rac1
by HACE1 is required to achieve the control of Rac1 activity in
cells.
CNF1 belongs to a group of bacterial toxins targeting Rho
proteins, notably Rac1, for activation (Aktories, 2011; Boquet
and Lemichez, 2003; Lemonnier et al., 2007). Both the activation
and UPS-mediated degradation of Rac1 confer to bacteria high
tissue and cell invasive properties (Doye et al., 2002; Falzano
et al., 1993; Visvikis et al., 2011). Consistent with these previous
findings, our data indicate that HACE1 is required for efficient
invasion of endothelial cell monolayers by UPEC. Given the
central role of Rac1 in host defenses against pathogens through
the regulation of apoptosis, phagocytosis, as well as production
of reactive oxygen species and inflammatorymediators, it will be
of interest to decipher the contribution of HACE1 in these key
cellular processes (Boquet and Lemichez, 2003). Beyond these
classical aspects of host pathogen interactions are evidence
pointing for CNF1 as a potential carcinogen in link with its
capacity to deregulate cell cycle completion and control apo-
ptosis (Travaglione et al., 2008). It will be of interest to determine
the role of HACE1 in these aspects considering its reported
function as a critical tumor suppressor (Zhang et al., 2007).
Rac1 signaling plays important roles in tumorigenesis (Vega
and Ridley, 2008). It is tempting to speculate that HACE1 tumor
suppressor activity could be mediated via its action on Rac1.
Inhibitors designed to inactivate Rac1 might thus represent
promising therapeutic drugs in cancers involving HACE1 inacti-
vation (Gao et al., 2004).
EXPERIMENTAL PROCEDURES
An expanded Supplemental Experimental Procedures section is available
online, including list of plasmids, siRNA, antibodies and reagents, and QPCR
primer sequences.
Cell Culture and Transfection
Human embryonic kidney cells (HEK293), human umbilical vein endothelial
cells (HUVECs), and Chinese hamster ovary cells (CHO) were grown and
transfected as described in Boyer et al. (2006) and Doye et al. (2006). SiRNA
(100 nM) were transfected using PolyMag reagent (OZ Biosciences).
Screening Method
HUVECs (104 cells) were seeded into 96-well plates and transfected in tripli-
cate with 100 nM siRNA control or pools of four oligonucleotides targeting
HECT-domain containing E3 ubiquitin-ligases (Dharmacon). Twenty-four
hours later, cells were intoxicated with 108 M CNF1 for a 24-hr period.
Rac1 levels were assessed by ELISA on fixed cells.
Ubiquitylation Assays
For in vivo ubiquitylation measurements, CHO or HEK293 cells (5 3 106) were
transfected with 10 mg of His-tagged ubiquitin WT or K48R expression vectors
together with HA or Flag-tagged Rac1 (WT, L61, and E61) and either HA-
tagged HACE1 constructs or siRNA targeting HACE1. Ubiquitylated proteins964 Developmental Cell 21, 959–965, November 15, 2011 ª2011 Elswere recovered by His-tag affinity purification on cobalt resin in urea dena-
turing conditions, as described in Doye et al. (2006). For in vitro ubiquitylation
reaction, Rac1 and HACE1 proteins were purified in E. coli, using standard
GST and His-tag purification methods (Flatau et al., 1997; Doye et al., 2006).
Reactions were carried out with 0.3 mg Rac1, 0.35 mg rabbit E1 ubiquitin acti-
vating enzyme (Boston Biochem), 0.4 mg UbcH7 recombinant E2 enzyme
(Boston Biochem), and 10 mg of ubiquitin (Calbiochem) in 20 ml of ubiquitylation
buffer (50 mM Tris-HCl [pH 7.5], 10 mM MgCl2, 0.05 mM DTT, supplemented
with 5 mM ATP), as described in Wang et al. (2003). Rac1 was loaded with
GTP, GTPgS, GDP, or left in its Mg2+-free GDP/GTP-empty form, as described
in Self and Hall (1995).
Pull-Down, Immunoprecipitation, and Immunoblot
Activated Rac1 pull-down using GST-PAK70–106 is described in Doye et al.
(2006). For in vitro assay, we used 1 mg Rac1 and 30 mg GST-PAK70–106. Immu-
noprecipitation was performed in HEK293 (107 cells) transfected with both
10 mg of Flag-tagged Rac1 WT or mutants and 10 mg HA-tagged HACE1
constructs, as described in Visvikis et al. (2011). Immunoblots were imaged
and quantified using the Fujifilm LAS-3000 and Fujifilm MultiGauge V3.0
software.
Microscopy Techniques
Immunofluorescence studies were carried as described in Visvikis et al. (2011).
The circularity index of cell shape was quantified as previously described
(Patel et al., 2008). For application of circularity measurements of cells, a free-
hand selection option in ImageJ software was used to delineate cell outline.
Circularity index values were assigned to cell outlines by the ImageJ circularity
plugin (http://rsb.info.nih.gov/ij/plugins/circularity.html) where circularity =
4p(area/perimeter2).
Bacterial Internalization
Bacterial internalization was measured using a gentamicin protection assay as
previously described (Doye et al., 2002; Visvikis et al., 2011). Briefly, HUVECs
transfected with siRNA for 24 hr were seeded at 105 cells in 35 mm well and
left untreated or intoxicated 24 hr with CNF1 109 M. Cell monolayers were
infected with 10:1 exponentially growing J96Dcnf1 (Visvikis et al., 2011), grown
in static conditions to DO600 = 0.8. Internalization of UPEC represents a ratio
of internalized bacteria to cell associated bacteria normalized to control
conditions.
Statistical Analysis
Data were analyzed with Prism 5.0b (GraphPad Software) by one-way ANOVA
with Bonferroni post hoc (*p% 0.05; **p < 0.01, ***p < 0.001).SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and Supplemental
Experimental Procedures and can be found with this article online at
doi:10.1016/j.devcel.2011.08.015.
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